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Abstract
Background: Co-occurring severe mental and substance use disorders are associated with physical, psychological
and social complications such as homelessness and unemployment. People with severe mental and substance use
disorders are difficult to engage with care. The lack of treatment worsens their health and social conditions and
increases treatment costs, as emergency department visits arise. Case management has proved to be effective in
promoting engagement with care of people with severe mental and substance use disorders. However, this impact
seemed mainly related to the case management model. The Intensive Case Management for Addiction (ICMA) aimed
to improve engagement with care of people with severe mental and substance use disorders, insufficiently engaged
with standard treatment. This innovative multidisciplinary mobile team programme combined Assertive Community
Treatment and Critical Time Intervention methodologies. The aim of the study was to observe the impact of ICMA
upon service use, treatment adherence and quality of support networks. Participants’ psychosocial and mental
functioning, and substance use were also assessed throughout the intervention.
Methods: The study was observational. Eligible participants were all the people entering the programme
during the first year of implementation (April 2014–April 2015). Data were collected through structured
questionnaires and medical charts. Assessments were conducted at baseline and at 12 months follow-up
or at the end of the programme if completed earlier. McNemar-Bowker’s Test, General Linear Model
repeated-measures analysis of variance and non-parametric Wilcoxon Signed Rank tests were used for
the analysis.
Results: A total of 30 participants took part in the study. Results showed a significant reduction in the
number of participants visiting the general emergency department compared to baseline. A significantly
decreased number of psychiatric emergency department visits was also registered. Moreover, at follow-up
participants improved significantly their treatment adherence, clinical status, social functioning, and substance
intake and frequency of use.
Conclusions: These promising results highlight the efficacy of the ICMA. The intervention improved
engagement with care and the psychosocial situation of people with severe mental and substance use
disorders, with consequent direct impact on their substance misuse.
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Background
Only a minority of people with co-occurring severe
mental and substance use disorders seek help and are
treated for their problems [1–3]. On a personal level,
important identified barriers to treatment are symp-
toms, lack of awareness of being in need of help,
stigma or social problems such as homelessness or
insufficient financial resources. On a structural level,
the service location and organisation or the unavail-
ability of addiction specialists have been recognised as
care access limitations [4, 5]. Absence of care can
lead to health and social complications and contrib-
utes to higher costs of public services as emergency
department visits arise [6]. Different models of case
management have proved to be effective in promoting
engagement with care of people with substance use
disorders in a variety of settings [7–9]. Case manage-
ment also showed to reduce substance misuse among
homeless people with severe mental illness [10]. How-
ever, the impact of these interventions seemed to be
mainly determined by the case management reference
model [11]. Assertive community treatment (ACT)
improved housing stability and was cost-effective for
homeless people with severe mental and substance
use disorders, reducing inpatient and emergency
department visits. Critical Time Intervention (CTI)
showed promise for housing support, psychiatric
symptoms and substance use in this population.
In 2001, an Intensive Case Management (ICM)
programme for people with severe mental disorders (in
French Suivi Intensif dans le milieu-SIM), was developed
and tested in Lausanne, Switzerland, an urban area of
265′000 inhabitants [12]. The intervention combined
the Assertive Community Treatment (ACT) [13, 14] and
the Critical Time Intervention [15] methodologies. As in
the ACT model, case managers and psychiatrists pro-
vided home visits when needed. A caseload limited to a
maximum of 20 clients per full-time professional
allowed case managers to spend more time with each
person and to intensify the follow-up during crisis
periods. The multidisciplinarity of the team granted an
approach that was not exclusively focused on the illness.
Each professional could discuss and provide specific help
on a wider range of issues, such as housing or income.
These specificities of ACT are key elements that contrib-
ute to clients’ satisfaction and promote their engagement
with care [16]. The ICM programme in Lausanne dif-
fered from ACT in three aspects. First, because of a lack
of resources, the team was only available between 8 a.m.
and 6 p.m. During nights and weekends, clients could be
referred to the local psychiatric emergency department
(ED). Second, situations were regularly discussed among
team members, but each client was followed by a spe-
cific case manager and by the psychiatrist when no other
doctor was involved in the situation. Third, the team
members only delivered services that other professionals
could not provide, such as intensive home visits or prac-
tical help for time consuming administrative procedures.
This led to a closer collaboration with other members of
the health and social network and made discharge
towards other services easier. The ICM programme bor-
rowed also elements from the critical time intervention
model (CTI) [15]: 1. The intervention was time-limited
to critical or transitional periods; 2. It aimed to engage
clients with other services through a smooth process; 3.
During the programme, it offered a psychological as well
as a practical help adapted to client’s needs; 4. Client’s
resources and limitations were assessed in vivo and
practical solutions proposed.
In Lausanne, the ICM intervention has proved to be ef-
fective in promoting engagement with care of people with
severe mental illness and improving both their clinical and
social functioning [17]. These results were in line with
international studies on ICM for severe mental disorders
that have shown to reduce hospitalisations, increase
participants retention in care and improve their social
functioning [18]. Based on the ICM model, in 2014 a pilot
project of Intensive Case Management for Addiction
(ICMA) (in French Suivi Intensif dans le milieu pour les
problèmes d’addiction - SIMA) was developed and imple-
mented in the same area. The programme was tested with
a group of hard-to-reach people with severe mental and
substance use disorders, who have difficulties to engage
with addiction or psychiatric services. This paper presents
findings from the ICMA observational study.
Aims of the study
The main aim of the study was to test whether ICMA
improved engagement with care of people with severe
mental and substance use disorders. Specifically,
expected primary outcomes were: decreased rates of
unplanned service use and involuntary hospitalisations,
improved level of treatment adherence and enhanced
quality of primary (relatives) and secondary (caregivers)
support networks. The secondary objective was to evalu-
ate the programme impact on participants’ well-being
through the measure of their social conditions (housing,
legal status and criminal records), clinical status, social
functioning, and alcohol and other illicit drug use.
Methods
Sample
The ICMA programme was addressed to people with se-
vere mental and substance use disorders hard-to-reach
or refusing traditional addiction or psychiatric treatment.
ICMA participants repeatedly failed to attend outpatient
appointments and/or were involuntarily hospitalised
with no ambulatory care options after discharge. Eligible
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study participants were every consecutive person enter-
ing the programme during the first year of implementa-
tion between April 2014 and April 2015. Inclusion
criteria for the programme were: to be aged between 18
and 65 years and to live in the urban area of Lausanne,
Switzerland. Exclusion criterion for the programme was
the participant’s ability to collaborate with an addiction
treatment or the psychiatric services. Data were col-
lected through structured questionnaires and medical
charts. Assessments were conducted at baseline (T0)
and at 12 months follow-up or at the end of the
programme if completed earlier (T1).
During the first year of implementation, 30 partici-
pants entered the programme and were eligible for the
study (Table 1). They were mainly male (73%), single
(63%) and with an average age of 39 years. Half were
Caucasian (50%) while 30% were mixed-race. Only 33%
were native of Switzerland. Ninety-seven percent were
unemployed, although 37% had achieved a secondary or
higher education degree. The primary diagnosis was
mental and behavioural disorder due to psychoactive
substance use (57%), especially alcohol (59%), followed
by schizophrenia, schizotypal and delusional disorders
(20%), affective disorder (13%) and personality disorder
(10%). Eighty-three percent of the participants were hos-
pitalized at least once in their life, the average age of first
admission was 31 years and 57% had at least one invol-
untary hospitalization. More detailed socio-demographic
and clinical characteristics of the participants were pub-
lished elsewhere [2].
Intervention description
Two full-time case managers, one nurse and one social
worker, and a 20% psychiatrist were recruited for the
project. Participants were addressed to ICMA
programme by their relatives, or by their health or social
professionals. Programme admission and objectives were
discussed during multidisciplinary team meetings. When
needed, contacts were made with other professionals
already involved in the situation. If inclusion criteria
were met, the situation was assigned to a case manager.
The referring relative or professional had to be present
during the first contact with the participant in order to
share their concerns and to explain why the intervention
was requested. If the participant disagreed with the con-
cerns of the referring relative or professional, they were
encouraged to express their own expectations and needs.
The intervention was then focused on the participant’s
agenda. Most of the time, participants identified a social
problem, such as finding a home or a source of income,
as their main concern. This allowed the case managers
or the psychiatrist to provide a practical support and to
develop the therapeutic relationship. This practical help
also gave the opportunity to follow the participant
during their daily activities and to assess their resources
and limitations in vivo. Based on these observations, the
participant’s support network and the recovery plan were
progressively developed.
The programme was completed when another
addiction treatment or psychiatric service was per-
manently in charge of the participant. The decision to
end the ICMA was always taken by the case manager
in accordance with the participants and the other care
providers. The intervention could also end if partici-
pants moved out of the catchment area, if they were
lost to follow-up, if they refused to go on with the
programme or in case of death.
Table 1 Baseline characteristics (N = 30)
Characteristics
Demographics
Age (mean ± SD) 38.90 ± 10.50
Sex, % Male (n) 73.3% (22)
Education % (n)
None 23.3% (7)
Compulsory education 40.0% (12)
Secondary education 30.0% (9)
Tertiary education 6.7% (2)
Marital status % (n)
Single 63.3% (19)
Married/Registered partnership 6.7% (2)
Other a 30.0% (9)
Ethnicity % (n)
Caucasian 50.0% (15)




% Born in Switzerland (n) 33.3% (10)
Employment status
% Unemployed (n) 96.7% (29)
Clinical history % (n)
Age of first admission (mean ± SD) 30.84 ± 10.32
Hospitalized at least once 83.3% (25)
Hospitalized at least once involuntary 56.7% (17)
Main diagnosis (ICD-10) % (n)
Mental and behavioural disorders due to psychoactive
substance use (F10-F19)
56.7% (17)
Schizophrenia, schizotypal and delusional disorders
(F20-F29)
20.0% (6)
Mood [affective] disorders (F30-F39) 13.3% (4)
Disorders of adult personality and behaviour (F60-F69) 10.0% (3)
Note. a divorced/widowed/separated; b person of mixed race
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Measures
Socio-demographic characteristics, diagnoses and clin-
ical history data were collected at baseline through
structured questionnaires and medical charts. Primary
and secondary outcomes measures were assessed at
baseline (T0) and at 12 months follow-up or at the end
of the programme if completed earlier (T1).
Primary outcomes
The primary outcome measures focused on service use,
treatment adherence and quality of primary (relatives)
and secondary (caregivers) support networks. Service
use data before and during programme were provided
by medical charts. Namely, the researchers assessed
whether or not participants had been hospitalized (vol-
untary and/or involuntary) in a psychiatric or addiction
treatment unit or had been admitted in the general or
psychiatric ED at least once during the reference period.
The frequency of readmission and contact with the ED,
and the number of inpatient days were also recorded.
Treatment adherence was assessed by case managers
on the basis of two items rating appointment and medi-
cation adherence on a visual-analogic scale ranging from
0 (no adherence) to 100 (total adherence). Two other
treatment adherence items assessing psychotropic medi-
cation compliance and appointment attendance were in-
corporated in the Health of the Nation Outcome Scale
(HoNOS) [19], which is routinely assessed by clinicians
at the institutional level. The HoNOS evaluates mental
and social functioning through 12 observer-rated items,
quoted on a Likert – type scale from 0 (no problems
during the reporting period) to 4 (severe to very severe
problem during the reporting period). The French
HoNOS has been shown to have moderate internal
consistency, excellent test-retest reliability and good
inter-rater reliability [20]. The predictive validity of
HoNOS has always been modest and the French version
is no exception. However it has been shown to be suit-
able for use at the item level for discriminating clinically
meaningful clusters of patients [21].
The quality of primary and secondary support networks
was evaluated by case managers through the Support Net-
work Scale [22], with anchors ranging between 1) adequate
and helpful, and 2) inadequate (gathering the answers:
exhausted and overwhelmed, inactive and unstable, inad-
equate and incompetent, absent and nonexistent).
Secondary outcomes
Secondary outcome measures combined data on partici-
pants’ housing conditions (stable housing vs. homeless),
legal status (legal guardianship, involuntary hospitalization
and/or penal measures underway), criminal records (num-
ber of participants with at least one crime, infraction and/
or victimisation occurred during the previous 12 months),
psychosocial and mental functioning, and alcohol and
other illicit drug use in the previous 30 days.
To assess participants’ psychosocial and mental func-
tioning several validated and widely used scales were de-
ployed. The 12 observer-rated items of the HoNOS [19]
were assessed. Item-level scores rather than composite
scores were used in the analysis [21]. The Crisis Triage
Rating Scale (CTRS) assess participants’ dangerousness,
ability to cooperate and support system on the basis of
three Likert – type subscales ranging from 0 (no problems
during the reporting period) to 4 (severe to very severe
problem during the reporting period) [23, 24]. The
subscales Ability to cooperate and Support system were
also analysed as primary outcome measures of treatment
adherence and quality of primary and secondary support
networks. The CTRS has been validated in English,
showing good reliability and validity [23, 24]. The French
version has been shown to be sensible to change in asser-
tive community treatment settings [17].
The Global Assessment of Functioning Scale (GAF)
rates the participants’ social, occupational and psycho-
logical functioning on a numeric scale from 1 to 100
[25]. The Clinical Global Impression – Severity scale
(CGI-S) evaluates illness severity at the time of assess-
ment on a 7-point scale quoting from 1 (normal) to 7
(among the most extremely ill) [26]. The GAF (which is
the DSM-IV fifth axis) and CGI-S are clinical global im-
pression scales for which inter-rater reliability has been
shown to be satisfactory to excellent [27, 28].
Alcohol and other illicit drug use in the previous
30 days were self-reported. A structured questionnaire
was administered by case managers to assess whether or
not participants had been using alcohol and/or other
illicit drug at least once during the last month. Namely,
the case managers aimed at assessing the alcohol and
other illicit drug use frequency, the average number of
alcohol units consumed per drinking day and if the
participants had been part at least one time of a heavy
alcohol use episode (> than 10 alcohol units).
Statistical analysis
Primary and secondary dichotomous outcomes were ana-
lysed using McNemar-Bowker’s exact test. General Linear
Model repeated-measures analysis of variance was per-
formed for continuous and ordinal variables. Highly
skewed continuous and ordinal variables were analysed
using non-parametric Wilcoxon Signed Rank tests.
Baseline data were compared with 12 months follow-
up measures or with final assessment if the programme
was completed earlier.
In order to verify whether longer engagement in the
programme impacted outcomes at T1, the relationship be-
tween programme duration and the outcomes’ variations
(T0 vs. T1) was tested using Spearman’s rank correlation
Morandi et al. Substance Abuse Treatment, Prevention, and Policy  (2017) 12:26 Page 4 of 10
coefficient. These analyses revealed no impact of the
programme duration on the outcomes.
Services use data, before and during programme, were
compared over the same time span (i.e.: 6 months before
vs. 6 months during programme; 8 months vs. 8 months;
etc.) based on each individual programme length, but no
longer than the 12 months evaluation point.
Assuming a sample size of 30 and interest in moderate
sized effects (i.e., Cohen’s d ≥ 0.5; described as observable
and noticeable to the eye of the beholder) and using a
conservative estimate of the correlation between time 1
and time 2 measurements, 72% power for the comparison
of pre- and post-measurements could be achieved adjust-
ing for the use of the Wilcoxon test. Assuming even a rea-
sonable correlation between the first and the second
measurements (r = 0.7), the power becomes 90.8% which
could be considered as more than adequate. Deviations
from normality would further increase power.
All statistical tests were two-tailed and significance
level was set at .05. Statistical analyses were performed
with the IBM SPSS statistical package version 23.
Results
Out of 30 participants enrolled at the baseline, 17 were
still undergoing the programme after 12 months while
13 had completed it. At the end of ICMA intervention,
2 participants were transferred to other services of the
Department of psychiatry, 2 to the alcohology service, 2
to private psychiatrists, 3 to other psychosocial services
and 3 were not referred to any service (one improved
sufficiently, one moved and the last one refused to be re-
ferred to another service). One 50 years old participant
died during the programme. The cause of the death was
undetermined. The mean programme duration was
10.00 ± 2.83 months. During the first year of implemen-
tation, each participant had on average 1.25 contacts per
week with the case manager (1.07 h per week).
Primary outcomes
No significant influence of the programme duration on
the primary outcomes’ variations was found.
Longitudinal analysis comparing service use over
the same time span before and during programme
(Table 2) showed a significant decreased rate of
general ED contacts (73% to 50%; p = .039). The de-
crease in the number of contacts with the psychiatric
ED (Wilcoxon z = −1.997; p = .046; r = −.36) was
also significant, with on average 0.60 ± 1.22
(Mdn = 0.0; IQR = 1) contacts before starting the
programme and 0.20 ± 0.55 (Mdn = 0.0; IQR = 0)
during the following period. No significant differences
were found for the number of voluntary and involun-
tary psychiatric hospitalisations, the number of gen-
eral ED visits and the number of total inpatient days.
The decreased rate of involuntary hospitalizations
(33% to 13%) did not reach statistical significance.
Participants’ treatment adherence improved signifi-
cantly during the programme (Table 3). At T1, partici-
pants scored significantly better on medication
adherence (F(1,23) = 15.754, p = .001, ƞp2 = .407) and ap-
pointment adherence (F(1,29) = 9.604, p = .004, ƞp2 = .249).
Besides, the severity scores on the two additional HoNOS-
based items testing participants’ appointment attendance
(F(1,27) = 12.911, p = .001, ƞp
2 = .323) and psychotropic
medication compliance (F(1,23) = 10.827, p = .003, ƞp
2
= .320) decreased significantly. The enhanced participants’
compliance was also confirmed by the reduced score
achieved at T1 on the CTRS Ability to Cooperate subscale
(F(1,28) =16.605, p < .001, ƞp
2 = .372).
Finally, the support network quality improved signifi-
cantly. Sixty-seven percent of the participants’ primary
(relatives) and secondary (professionals) networks were
described by case managers as “adequate and helpful” at
T1 versus only 10% at baseline (p < .001). A significant
improvement was also achieved on the CTRS Support
System subscale (F(1,27) = 12.680, p = .001, ƞp2 = .320).
Table 2 Longitudinal analysis comparing services use over the same time span before and after programme enrolment
Services use Before (N = 30) After (N = 30) Test p-value
Psychiatric hospitalisation % (n) 63.3% (19) 53.3% (16) a .508
Involuntary hospitalisation % (n) 33.3% (10) 13.3% (4) a .070
Psychiatric ED visit % (n) 30.0% (9) 13.3% (4) a .125
General ED visit % (n) 73.3% (22) 50.0% (15) a .039
Number of psychiatric hospitalisations Mdn (IQR) 1.0 (2) 1.0 (2) z = −0.354b .723
Number of involuntary hospitalisations Mdn (IQR) 0.0 (1) 0.0 (0) z = −1.327b .185
Number of psychiatric ED visits Mdn (IQR) 0.0 (1) 0.0 (0) z = −1.997b .046
Number of general ED visits Mdn (IQR) 2.0 (3) 0.5 (2) z = −1.573b .116
Number of inpatient days Mdn (IQR) 22.0 (45) 6.5 (49) z = −0.503b .615
Note. a McNemar-Bowker’s Test; b Wilcoxon Signed Rank test; Mdn median, IQR interquartile range
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Secondary outcomes
Secondary outcomes are reported in Table 3. No signifi-
cant influence of the programme duration on the sec-
ondary outcomes’ variations was found.
Participants’ psychosocial and mental functioning
improved significantly during the programme. The item-
level HoNOS analysis showed significant ameliorations at
T1. After 12 months (or at the end of the programme if
completed earlier), participants decreased their severity
scores on eight items out of 12: Non-accidental self-injury
(F(1,28) = 4.589, p = .041, ƞp2 = .141), Problem drinking or
drug-taking (F(1,28) = 24.852, p < .001, ƞp2=.470), Cognitive
problems (F(1,28)=7.965, p = .009, ƞp
2 = .221), Problems
with depressed mood (F(1,27) = 27.842, p < .001,ƞp2 = .508),
Table 3 Clinical and social within-group changes at 12 months follow-up or at the end of the programme if completed earlier (T1)
compared to baseline (T0)
Outcome measures T0 (N = 30) T1 (N = 30) p-value
Housing conditions
% Homeless (n) 24.1% (7) 6.9% (2) .125a
Legal status % (n)
Legal guardianship underway 63.3% (19) 73.3% (22) .375a
Involuntary hospitalization underway 30.0% (9) 23.3% (7) .687a
Penal measure underway 13.3% (4) 16.7% (4) 1.000a
Criminal records during the previous 12 months (N = 17) % (n)
Crime or infraction 47.1% (8) 35.3% (6) .688a
Victimisation 35.3% (6) 5.9% (1) .063a
Treatment adherence (mean ± SD) (Visual-analogic scales)
Medication adherence 52.92 ± 32.36 78.75 ± 29.68 .001b
Appointments adherence 52.10 ± 34.22 74.50 ± 26.37 .004b
Network support scale % (n)
Adequate and helpful 10.0% (3) 66.7% (20) <.001a
Inadequate (exhausted,inactive, incompetent, absent) 90.0% (27) 33.3% (10)
CTRS (mean ± SD)
Dangerousness Subscale 2.79 ± 1.34 1.55 ± 1.29 <.001b
Support System subscale 2.75 ± 1.23 1.43 ± 1.34 .001b
Ability to cooperate subscale 2.69 ± 1.07 1.90 ± 1.01 <.001b
HoNOS items (mean ± SD)
Overactive, aggressive, disruptive or agitated behaviour 1.28 ± 1.53 0.83 ± 1.25 .130b
Non-accidental self-injury 0.79 ± 1.17 0.31 ± 0.85 .041b
Problem drinking or drug-taking 3.55 ± 0.87 2.52 ± 1.12 <.001b
Cognitive problems 2.24 ± 1.45 1.66 ± 1.39 .009b
Physical illness or disability problems 1.00 ± 1.27 0.79 ± 1.31 .364b
Problems associated with hallucinations and delusions 1.15 ± 1.40 0.81 ± 1.23 .071b
Problems with depressed mood 2.86 ± 1.24 1.46 ± 1.29 <.001b
Other mental and behavioural problems 2.36 ± 1.68 1.72 ± 1.30 .115b
Problems with relationships 2.97 ± 0.86 2.14 ± 0.99 <.001b
Problems with activities of daily living 2.93 ± 1.25 2.38 ± 0.97 .011b
Problems with living conditions 2.45 ± 1.68 1.45 ± 1.50 .003b
Problems with occupation and activities 3.41 ± 0.68 2.48 ± 1.09 <.001b
Appointments attendance (additional item) 2.32 ± 1.16 1.43 ± 1.16 .001b
Psychotropic medications compliance (additional item) 2.21 ± 1.71 1.13 ± 1.07 .003b
Clinical Global Impression – Severity scale (CGI-S) (mean ± SD) 5.45 ± 1.15 4.59 ± 1.05 .002b
Global Assessment of Functioning Scale (mean ± SD) 28.10 ± 9.93 37.28 ± 8.92 <.001b
Note. a McNemar-Bowker’s Test; b General Linear Model repeated-measure
Morandi et al. Substance Abuse Treatment, Prevention, and Policy  (2017) 12:26 Page 6 of 10
Problems with relationships (F(1,28) = 18.453, p < .001, ƞp2
= .397), Problems with activities of daily living (F(1,28) =
7.451, p = .011,ƞp2 = .210), Problems with living conditions
(F(1,28) =10.684, p = .003, ƞp2 = .276), Problems with occupa-
tion and activities (F(1,28) = 20.786, p < .001,ƞp2 = .426).
While only 5 of these results remained significant after correc-
tion for multiple comparison (Problem drinking or drug-
taking; Problems with depressed mood; Problems with
relationships; Problems with living conditions; Problems with
occupation and activities), the total number of significant dif-
ferences was well above what could be expected by chance
(12 × 0.05 = 0.6 comparison with p-values of .05 or lower).
A significant positive change was also registered on the
CTRS Dangerousness Subscale (F(1,28) = 31.832, p < .001,
ƞp2 = .532). These results were further confirmed by the
GAF and the CGI-S. Participants’ global functioning im-
proved significantly during the programme (F(1,28)
=24.207, p < .001, ƞp2 = .464) while CGI-S scores decreased
significantly (F(1,28)=11.290, p=.002, ƞp2 = .287).
Analysis showed no significant changes concerning
participants’ housing conditions and legal status. Never-
theless, only 7% of the participants were still homeless at
T1 compared to the 24% at T0. The decreased trend of
victimisations (35% to 6%) of participants between the
12 months before and after the beginning of the
programme was not significant.
Self-reported alcohol and other illicit drug use results
are reported in Table 4. Comparing T0 and T1, no
significant differences were found concerning the number
of alcohol consumers during the previous 30 days. Never-
theless, the average number of alcohol units consumed
per drinking day decreased significantly, from 12.26 ±
11.61 at the baseline to 5.48 ± 8.53 at T1 (F(1,26) = 8.246,
p = .008,ƞp2 = .241). Similar results were found for the rate
of heavy drinkers: while 71% of the participants had been
part at least once of a heavy alcohol use episode (> than 10
alcohol units) at T0, only 32% reported a similar episode at
T1 (p = .001). A significant result was also found at T1 for
the frequency of alcohol use (Wilcoxon z = −2.721,
p = .007).
The rate of other illicit drug use decreased significantly,
from 69% at baseline to 45% at T1 (p = .016). Further-
more, the frequency of use at T1 was significantly reduced
compared to the baseline (Wilcoxon z = −3.064, p = .002).
Discussion
Throughout the intervention, ICMA significantly reduced
the number of participants visiting the general ED and the
number of psychiatric ED visits. Moreover, at follow-up
participants showed significant improvements in their
treatment adherence, clinical status, social functioning
and the rates and frequency of alcohol and other illicit
drug use. These findings were in line with previous studies
on the effectiveness of ICM in population with severe
mental and substance use disorders [18, 29]. From the
local authorities’ point of view, they justified the high
Table 4 Alcohol and other illicit drug use within-group differences and 12 months follow-up or at the end of the programme if
completed earlier (T1) compared to baseline (T0)
Outcome measures T0 (N = 30) T1 (N = 30) Test p-value
Alcohol use during the last 30 days
% Consumers (n) 86.2% (25) 68.9% (20) a .125
Alcohol units per drinking day (mean ± SD) 12.26 ± 11.61 5.48 ± 8.53 F(1,26) = 8.246 .008
At least one episode of heavy alcohol use % (n) 71.4% (20) 32.1% (9) a .001
Frequency % (n)
Almost every day 51.7% (15) 27.6% (8) z = −2.721b .007
3–4 days per week 10.3% (3) 6.9% (2)
1–2 days per week 20.7% (6) 13.8% (4)
1–3 days per month 3.5% (1) 20.7% (6)
none 13.8% (4) 31.0% (9)
Other illicit drug use during the last 30 days
% Consumers (n) 68.9% (20) 44.8% (13) a .016
Frequency % (n)
Almost every day 27.6% (8) 6.9%(2) z = −3.064b .002
3–4 days per week 3.5% (1) 6.9% (2)
1–2 days per week 20.7% (6) 6.9% (2)
1–3 days per month 17.2% (5) 24.1% (7)
none 31.0% (9) 55.2% (16)
Note. a McNemar-Bowker’s Test; b Wilcoxon Signed Rank test; SD standard deviation
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costs of the programme due to the small caseload,
the high intensity of the intervention and the very
specific target population. However, the long term
programme cost-effectiveness should be assessed in
the future.
The ICMA intervention was able to overcome barriers
to care access on both the personal and the structural
level. On the personal level, immediate practical help
focused on participant’s needs allowed this latter to build
a strong relationship with the care provider avoiding
distrust and suspicion. The experience of a positive thera-
peutic relationship erased the memory of bad previous ex-
periences with care services such as coercion, and
overcame the addiction behaviours. On the provider’s
level, mobility, proactivity, commitment and availability of
care offered the opportunity to answer participants’
demands. Finally, on the system’s level, the intervention
mobilized the network, eased the care coordination and
allowed the development of new therapeutic options.
Emergency Department use, hospitalisation, coercion,
support network quality
Appointment attendance and medication compliance
increased during the intervention. Participants’ im-
proved treatment adherence significantly reduced the
rate of admission to the general ED and the number
of psychiatric ED visits. However, no significant im-
pact was found on the number of people admitted to
the psychiatric hospital. This could be explained by
the heterogeneity of the sample. Before the interven-
tion, some participants were regularly hospitalised or
had had long inpatient stays. In these situations, the
ICMA allowed a prompt discharge and return into
the community. Other participants had had no
contact with care services for long periods before the
enrolment. Therefore, once in the programme, their
highly decayed health status required immediate
inpatient care. The small sample size did not allow
subgroup analysis that could have had possibly show dif-
ferences between “heavy service users” and participants
who avoided care before entering the programme as
highlighted by previous studies [30, 31]. If the rate and the
number of psychiatric admissions did not decrease, the
use of compulsion seemed positively, but not significantly,
reduced.
The quality of the support network was greatly im-
proved by the ICMA intervention. An important part
of the case managers’ and the psychiatrist’s work was
dedicated to develop and enhance the collaboration
with other social and health services as well as partic-
ipants’ relatives, and to improve care coordination.
On a system level, regular appointments with other
services’ management staff were organised. Moreover,
case managers weekly attended other services team
meetings. On a clinical level, regular contacts with
each member of the network were constantly
fostered.
Clinical and social outcomes and substance use
Most clinical and social outcomes improved during
the intervention. If the social functioning improve-
ments can easily be explained by the fact that case
managers and the psychiatrist provided practical help
and supported the participants during social proce-
dures, their clinical evolution needs to be further
discussed. Clinical improvements may be explained by
three factors. First, the introduction of medications or
a better compliance to the current treatment as well
as to the psychotherapeutic interventions may have
positively impacted the participants’ mental health
state. Secondly, ICMA may have broken the vicious
circle in which this population is often trapped. In
fact, severe substance use disorders are associated
with social dropout and inappropriate medical care.
In these conditions, participants’ needs are misunder-
stood. Help is often provided only during crisis
periods and mainly through compulsion (involuntary
admission or guardianship) [32, 33]. The use of coer-
cion can lead to increased anxiety, loss of self-esteem
and mood disorders, with a consequent intensification
of alcohol and other illicit drug consumption [34].
Focusing more attentively on participants’ primary
needs, ICMA offered them a new perspective on their
situation. The rapid changes in the participants’ social
context may have enhanced their sense of empower-
ment and self-confidence and given them hope, redu-
cing the rate and frequency of alcohol and other
illicit drug use. Conversely, the reduction of substance
intake may have decreased cognitive problems and
mood disorders, reduced behavioural problems such
as self-injury, eased participants’ relations with others
and prevented physical complications. This may have
positively influenced the number of ED visits.
While in need for further experimentation on a
larger sample, the intervention seemed to positively
influence the rates of homelessness and victimisation
in this highly vulnerable population during the
follow-up period. This former finding confirmed the
positive impact of ACT and CTI in improving hous-
ing stability and reducing the rate of homelessness
among people with severe mental and substance use
disorders [11]. The latter finding pointed at the
ICMA as an excellent approach to reduce victimisa-
tion among this highly vulnerable population which
gathers several risk factors such as severe mental and
substance use disorders, homelessness, and absence of
contact with psychiatric services [35, 36].
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Strengths and limitations
Regarding the strengths, this was a prospective explora-
tory study. Despite the difficult-to-engage target popula-
tion, none of the participants refused to take part in the
research project.
Two main methodological limitations were the absence
of a control group and the modest sample size. The inter-
vention was tested on a local level in Lausanne, an urban
area of 265′000 inhabitants in the French-speaking part of
Switzerland. Generalizability of the results may thus be re-
stricted. Besides, some measures were self-reported while
others were rated by the case managers.
Conclusion
Despite the limited scale of this observational project,
the results are promising, highlighting the efficacy of
ICMA methodology to improve engagement with care
and the psychosocial situation of this hard-to-reach
population, with consequent direct impact on substance
problems. Further research is needed to confirm the
programme effectiveness. However, the high-risk profile
of these participants and the dangers related to the lack
of an adapted care could represent an ethical and actual
obstacle to the assessment of this issue in a randomised
controlled trial setting.
The ICMA does not replace other addiction treatment
services. Its aim is to locate and design an alternative
way to promote participants’ engagement with standard
care and to offer people with severe mental and sub-
stance use disorders new opportunities, a better control
on their lives and an improved well-being.
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